Amgen vs Disney: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Amgen and Disney side by side

1. 1923Disney

   Disney Brothers Cartoon Studio is founded

   Walt Disney and Roy O. Disney formed the studio after Walt arrived in California with the Alice Comedies.

2. 1928Disney

   Mickey Mouse debuts in Steamboat Willie

   Steamboat Willie introduced Mickey Mouse to a broad audience with synchronized sound. The short helped Disney turn a technical change in cinema into a character asset that could be repeated, licensed, and expanded.

3. 1937Disney

   Snow White and the Seven Dwarfs is released

   Snow White and the Seven Dwarfs proved that feature-length animation could work as a premium theatrical event. Its success gave the studio credibility and capital for more ambitious animated films.

4. 1955Disney

   Disneyland opens in Anaheim

   Disneyland moved the company beyond screens and into physical entertainment. The park created a second economic model built on admission, food, merchandise, hospitality, and repeat family visits.

5. 1980Amgen

   Applied Molecular Genetics is incorporated

   Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.

6. 1983Amgen

   Nasdaq listing and the erythropoietin clone

   Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.

7. 1984Amgen

   Kirin-Amgen joint venture formed

   Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.

8. 1985Amgen

   G-CSF cloned, leading to Neupogen

   While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.

9. 1989Amgen

   FDA approves Epogen

   The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.

10. 1991Amgen

    Neupogen approved, giving Amgen a second franchise

    The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.

11. 1991Amgen

    Amgen wins the erythropoietin patent fight

    On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.

12. 1996Disney

    Capital Cities/ABC brings ESPN to Disney

    Disney stockholders approved the Capital Cities/ABC merger in 1996, bringing ABC and ESPN into the company. ESPN later became central to Disney's television economics and is now central to its cord-cutting risk.

13. 2001Amgen

    FDA approves Aranesp, the longer-acting EPO

    Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.

14. 2002Amgen

    US$16 billion Immunex acquisition brings Enbrel in-house

    Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.

15. 2005Disney

    Robert A. Iger becomes CEO

    Iger became CEO in 2005 after serving as Disney president and chief operating officer. His tenure reshaped the company through Pixar, Marvel, Lucasfilm, 21st Century Fox assets, international expansion, and direct-to-consumer streaming.

16. 2006Disney

    Pixar Animation Studios is acquired

    The $7.4B Pixar deal ended a strained distribution relationship and brought creative leadership, computer-animation expertise, and a strong story process into Disney. It helped restore animation momentum and set the template for later franchise acquisitions.

17. 2009Disney

    Marvel Entertainment is acquired

    Disney agreed to acquire Marvel in a transaction valued at about $4B. The deal added more than 5,000 characters and expanded the company's reach in theatrical films, consumer products, streaming, and parks.

18. 2010Amgen

    Prolia and XGEVA create the bone health franchise

    The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.

19. 2012Disney

    Lucasfilm joins Disney

    The Lucasfilm acquisition was valued at $4.05B and brought Star Wars, Indiana Jones, Industrial Light & Magic, and related production assets. It gave Disney a global franchise with theatrical, streaming, merchandise, games, and parks potential.

20. 2019Amgen

    US$13.4 billion purchase of Otezla from Celgene

    Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.

21. 2019Disney

    Disney signs amended 21st Century Fox acquisition agreement

    The amended Fox agreement valued the equity consideration at about $71.3B and expanded Disney's content library, international assets, and Hulu position. It was a scale move made as Disney prepared for a streaming-centered media market.

22. 2019Disney

    Disney+ launches

    Disney+ launched in the United States, Canada, and the Netherlands with nearly 500 films and 7,500 television episodes. The service moved Disney closer to consumers and made streaming economics a core investor question.

23. 2020Amgen

    Amgen joins the Dow Jones Industrial Average

    Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.

24. 2020Disney

    Bob Chapek leads through pandemic disruption

    Chapek became CEO shortly before COVID-19 disrupted parks, cruises, theaters, and production. The period exposed Disney's dependence on physical attendance while accelerating demand for direct-to-consumer streaming.

25. 2023Amgen

    US$27.8 billion Horizon Therapeutics acquisition closes

    Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.

26. 2024Amgen

    Imdelltra becomes the first T-cell engager for small cell lung cancer

    The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.

27. 2025Amgen

    VESALIUS-CV extends the Repatha case to primary prevention

    In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.

28. 2025Disney

    $94.425B revenue and $12.404B net income

    FY2025 results showed the scale of Disney's current base across Entertainment, ESPN, and Experiences. The figures shift the analysis from simple revenue recovery to the quality of earnings, streaming profit, and park capital returns.

29. 2026Amgen

    Medicare price setting reaches Enbrel and Otezla

    Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.

30. 2026Disney

    Josh D'Amaro becomes CEO

    Disney's board unanimously elected Josh D'Amaro CEO effective March 18, 2026, with Robert A. Iger moving to senior advisor and Dana Walden becoming President and Chief Creative Officer.

Acquisitions

Questions about Amgen vs Disney